Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177722 | SCV000229640 | uncertain significance | not provided | 2017-12-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001078692 | SCV001015672 | likely benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-09-25 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000177722 | SCV001716007 | uncertain significance | not provided | 2021-01-04 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000177722 | SCV003809110 | likely benign | not provided | 2023-05-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004737280 | SCV005353670 | likely benign | PLEC-related disorder | 2024-08-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |